Shares of Koninklijke Philips (NYSE:PHG – Get Free Report) have received an average recommendation of “Hold” from the five brokerages that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company.
Several research analysts have recently weighed in on PHG shares. StockNews.com downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th. Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th.
View Our Latest Report on Koninklijke Philips
Koninklijke Philips Price Performance
Hedge Funds Weigh In On Koninklijke Philips
Several hedge funds and other institutional investors have recently modified their holdings of PHG. Fairscale Capital LLC purchased a new stake in Koninklijke Philips during the 2nd quarter valued at about $54,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Koninklijke Philips in the third quarter valued at approximately $54,000. Eastern Bank acquired a new stake in shares of Koninklijke Philips in the third quarter valued at approximately $88,000. RPg Family Wealth Advisory LLC purchased a new position in Koninklijke Philips during the third quarter worth approximately $107,000. Finally, Headlands Technologies LLC lifted its position in Koninklijke Philips by 43.9% during the second quarter. Headlands Technologies LLC now owns 6,561 shares of the technology company’s stock worth $165,000 after buying an additional 2,003 shares in the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- 3 Tickers Leading a Meme Stock Revival
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Do S&P 500 Stocks Tell Investors About the Market?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.